Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada,…

Drug Manufacturers - General

US, Foster City [HQ]

Board & Officers
Business Intelligence
Employee Voice
Mergers and Acquisitions
Qualified Risks
ESG Scores [Soon]

Strategy & Leadership

Officers & BofD Beta

All directors and officers of Gilead Sciences, Inc. are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).

Form 3/4/5
Proxy DEF-14A

Total Compensation

Shows the total compensation per mentioned executive and board director.
Each datapoint refers the most recent appearance of the corresponding person.

- No data, only available if we have DEF 14A compensations in place -

Officers

Name & Position	Research
Berger Dietmar Chief Medical Officer	Transactions Compensations Speech	01/03/25 [Form 4]
Dickinson Andrew D Chief Financial Officer	Transactions Compensations Speech	12/17/24 [Form 4]
Patterson Sandra SVP, Controllership	Transactions Compensations Speech	12/16/24 [Form 4]
Telman Deborah H EVP, Corporate Affairs & GC	Transactions Compensations Speech	12/11/24 [Form 4]
Parsey Merdad Chief Medical Officer	Transactions Compensations Speech	12/11/24 [Form 4]
O'Day Daniel Patrick Chairman & CEO Also inside the BofD	Transactions Compensations Speech	12/11/24 [Form 4]
Mercier Johanna Chief Commercial Officer	Transactions Compensations Speech	12/11/24 [Form 4]

Board of Directors (BofD)

Name & Position	Research
Bluestone Jeffrey Director	Transactions Compensations Speech	11/27/24 [Form 4]
Barton Jacqueline K Director	Transactions Compensations Speech	05/09/24 [Form 4]
Love Ted W Director	Transactions Compensations Speech	05/09/24 [Form 4]
Rodriguez Javier Director	Transactions Compensations Speech	05/09/24 [Form 4]
Horning Sandra Director	Transactions Compensations Speech	05/09/24 [Form 4]
Kramer Kelly A. Director	Transactions Compensations Speech	05/09/24 [Form 4]
Lofton Kevin E Director	Transactions Compensations Speech	03/29/24 [Form 4]